ScienceNot yet confirmed elsewhere1 publisher2 min readPublished
Tunisia, Egypt and Senegal run national genome projects against a 0.15% African share of GWAS participants
Only about 0.15% of genome-wide association study participants are African, a geneticist at Tanzania's Muhimbili University writes. The paper argues national genome projects improve care only with local expertise, data governance and sustained investment.
The Scientist · Science desk
Key figures. Roughly one genome-wide association study participant in 670 is from Africa, at 0.15%. Senegal aims to include people from 31 ethnolinguistic groups across all 14 regions.
| Figure | Value | Note | Claim |
|---|---|---|---|
| GWAS participants per one from Africa, roughly | 670 participants | 19 | |
| Groups Senegal aims to include | 31 ethnolinguistic | 8 | |
| Regions Senegal aims to include | 14 regions | 8 |
What happened
- Researchers found that some genetic changes reported as causing an inherited heart condition in people of African ancestry were actually harmless.
- Tunisia, Egypt and Senegal have national genome initiatives, while government-led projects in Tanzania, Kenya and South Africa are at earlier stages.
- Tunisia plans to study both people without known disease and patients with clinical conditions.
- Senegal aims to include people from 31 ethnolinguistic groups across all 14 regions, so that a national data set does not overlook parts of the population.
- Egypt aims to study a much larger number of people and to investigate both common and rare diseases.
Why it matters
- constraint The heart-condition errors were easier to detect once more African-ancestry data existed, so reading a test result for an African patient depends on collecting that data first.
- decision Each country has to choose its own mix of sample size, population coverage and clinical focus, because the authors argue no single approach will suit every country.
- precedent National projects start with laboratories, skills and collaborations that H3Africa already built, and the authors say they should build on that base.
At 0.15%, roughly one participant in 670 in a genome-wide association study is African [19]. The paper's author, a molecular geneticist at Muhimbili University of Health and Allied Sciences in Tanzania, describes Africa as holding the greatest human genetic diversity in the world [10][2].
The evidence that thin coverage distorts clinical interpretation rests, in this piece, on one example: the inherited heart condition whose variants in people of African ancestry turned out to be harmless. The piece does not say how often that happens, name the condition, count the variants or say how many patients carried a variant labeled that way. Its general claim is that findings drawn mostly from other populations can be harder to interpret for African patients [14].
In our view, Tunisia's design speaks most directly to that kind of error. The author says studying healthy people alongside patients could help distinguish harmless genetic differences from those relevant to a patient's illness [17].
According to the paper, Egypt's challenge will be a different one: to turn scale into useful knowledge and health care capacity [15].
The descriptions are of intent. Tunisia plans a study design, and Egypt and Senegal state aims [6][7][8]. For Tanzania, Kenya and South Africa the paper does not assess implementation [11]. The co-authors, based in Egypt, Tunisia, Senegal, Kenya and South Africa, work across genetics, genomics and population health [18].
The authors are explicit about what the projects are for. The aim is to build knowledge that is currently missing, along with the people and systems needed to use it [12].
What to watch
- Any follow-up on the Tanzanian, Kenyan and South African projects, which this paper does not assess.
- Whether Tunisia's mix of healthy participants and patients leads to variants being reclassified as harmless, as happened with the heart-condition changes.
- Whether Egypt turns its larger sample into health care capacity, the challenge the author names.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence40
- Adoption25
- Hype gap−10
- Incentives35
- Confidence45
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Only about 0.15% of participants in genome-wide association studies, which look for links between genetic differences and disease, are from Africa.
ReportedSupportedSource: phys.org article by a molecular geneticist at Muhimbili University of Health and Allied SciencesView cited source - [2]
Africa has the greatest human genetic diversity in the world, yet African populations remain poorly represented in global genomic research.
- [3]
Researchers found that some genetic changes previously reported as causing an inherited heart condition in people of African ancestry were actually harmless.
- [4]
Those errors were easier to detect once more genetic information from people of African ancestry became available.
- [5]
Tunisia, Egypt and Senegal have national genome initiatives, while government-led projects in Tanzania, Kenya and South Africa are at earlier stages.
- [6]
Tunisia plans to study both people without known disease and patients with clinical conditions.
- [7]
Egypt aims to study a much larger number of people and investigate common and rare diseases.
- [8]
Senegal aims to include people from 31 ethnolinguistic groups across all 14 regions, addressing the risk that a national data set overlooks parts of the population.
- [9]
The paper's authors argue that no single approach will suit every country, and that national projects should be designed around each country's health priorities and resources.
- [10]
The author is a molecular geneticist at Muhimbili University of Health and Allied Sciences in Tanzania.
- [11]
The paper does not assess the implementation of national genome project efforts in Tanzania, Kenya and South Africa.
- [12]
The aim is not to offer every person a genetic test; the value lies in building knowledge that is currently missing and developing the people and systems needed to use it.
- [13]
Human Heredity and Health in Africa (H3Africa) has already helped develop laboratories, research skills and collaborations across the continent, and the authors say national projects should build on this experience.
- [14]
When most of the evidence comes from populations outside Africa, some findings can be harder to interpret for African patients.
- [15]
Egypt's challenge will be to turn its scale into useful knowledge and health care capacity.
- [16]
The authors make the case that sequencing must be accompanied by local expertise, responsible data governance and sustained investment if it is to improve health care.
- [17]
Studying both people without known disease and patients could help distinguish harmless genetic differences from those relevant to a patient's illness.
- [18]
The co-authors bring expertise in genetics, genomics and population health from Egypt, Tunisia, Senegal, Kenya and South Africa.
- [19]
At 0.15%, roughly one GWAS participant in 670 is from Africa.
Sources
1 independent publisher whose own reporting we read for this story.
- phys.orgAfrican genomics research is growing: What countries are doing to connect genetic data and health care
1 article · October 12, 2026
Topics and entities
Follow any of these and your For You feed starts watching them — no settings page required.